Mirabegron for treatment of overactive bladder symptoms in patients with Parkinson's disease: A double‐blind, randomized placebo‐controlled trial (Parkinson's Disease Overactive bladder Mirabegron, PaDoMi Study)Sung Yong Cho, Seung‐June Oh, Jang Hwan Kim et al.|Neurourology and Urodynamics|2021Cited by 37